Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 7:00 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1969–1992 of 8,697 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Cardiovascular Diseases
Interventions: TruGenome Cardiovascular Disease test; Diagnostic Test
Lead sponsor: Illumina, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Gingival Recession
Interventions: Coronally Advanced Flap, Intrasulcular Tunneling, Vestibular Incision Subperiosteal Tunnel Access (VISTA), Leukocyte-Platelet Rich Fibrin (L-PRF); Procedure · Biological · Device
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hypertension
Interventions: Geneticure Panel for HTN therapy, JNC-8; Drug
Lead sponsor: Geneticure, LLC; Industry
Eligibility: 30 Years to 80 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 15
States / cities: Andover, Minnesota • Blaine, Minnesota • Bloomington, Minnesota + 12 more

Conditions: Weight Loss
Interventions: PLAGB will be studied and compared to the standard LAGB procedure through a dual center, prospective clinical trial.; Procedure
Lead sponsor: Jacksonville Surgical Associates; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 2
States / cities: Ventura, California • Jacksonville, Florida

Conditions: Traumatic Brain Injury
Interventions: SDx3; Device
Lead sponsor: Sense Diagnostics, LLC; Industry
Eligibility: 22 Years to 50 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Atlanta, Georgia • Cincinnati, Ohio

Conditions: Limb Fracture, Bone Loss
Interventions: Any treatment that is used for a defect of any long bone; Procedure
Lead sponsor: AO Innovation Translation Center; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: Los Angeles, California • Baltimore, Maryland

Conditions: Atrial Fibrillation
Interventions: pantoprazole, Pradaxa (dabigatran etexilate), Pradaxa, within 30 minutes after a meal; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 1,067 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 81
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 75 more

Conditions: HIV Infections, Lipodystrophy
Interventions: Pravastatin sodium, Fenofibrate; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 630 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2003
U.S. locations: 57
States / cities: Birmingham, Alabama • Los Angeles, California • Menlo Park, California + 33 more

Conditions: Cystic Fibrosis
Interventions: Observational; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 12 Years and older
Enrollment: 452 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 38
States / cities: Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 31 more

Conditions: Gestational Diabetes, Glucose Intolerance, Type 2 Diabetes, Intrauterine Contraception
Interventions: Mirena (Levonorgestrel IUD), Paragard (Copper IUD ) or Tubal Ligation; Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Gastrointestinal Disorders, Functional
Interventions: Online Cognitive Behavior Therapy, Online Education; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 11 Years to 17 Years
Enrollment: 344 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: BCC - Basal Cell Carcinoma, BCC, Excision Margin
Interventions: CellFX System; Device
Lead sponsor: Pulse Biosciences, Inc.; Industry
Eligibility: 22 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 5
States / cities: Vestavia Hills, Alabama • Beverly Hills, California • Clearwater, Florida + 2 more

Conditions: Diabetic Foot Ulcer
Interventions: Dual-layer perinatal tissue allograft, Three-layer fenestrated perinatal tissue allograft, Standard of care; Other
Lead sponsor: Samaritan Biologics; Industry
Eligibility: 18 Years and older
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Monroe, North Carolina

Conditions: Fungus Disease
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: Not listed
Enrollment: 217 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Pain, Postoperative
Interventions: bupivacaine and epinephrine, Placebo; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: HIV Infections
Interventions: Zidovudine; Drug
Lead sponsor: Glaxo Wellcome; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
Interventions: Globe Pulsed Field System; Device
Lead sponsor: Kardium Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 549 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 11
States / cities: Birmingham, Alabama • Jonesboro, Arkansas • San Francisco, California + 8 more

Conditions: Kidney Stone
Interventions: retrograde nephrostomy, antegrade nephrostomy; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Duodenal Neoplasm, Pancreatic Neoplasm
Interventions: Bupivacaine, Hydromorphone, Iopamidol, Liposomal Bupivacaine, Medical Chart Review, Questionnaire Administration, Thoracic Epidural Analgesia, Ultrasound Imaging, X-Ray Imaging; Drug · Other · Procedure
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Heavy Menstrual Bleeding, Menorrhagia, Uterine Fibroids
Interventions: Levonorgestrel IUS, Tranexamic Acid; Drug
Lead sponsor: Shannon K. Laughlin-Tommaso; Other
Eligibility: 25 Years to 50 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Jacksonville, Florida • Rochester, Minnesota

Conditions: Perioperative Nutrition
Interventions: Clear Liquids, Standard of Care; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Tooth Loss
Interventions: Control Collagen Wound Dressing, Test Collagen Matrix; Device
Lead sponsor: McGuire Institute; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Fenton, Michigan

Conditions: Osteoarthritis, Degenerative Joint Disease
Interventions: Hip Precautions, No Hip Precautions; Other
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,133 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Abdominal Aortic Aneurysm
Interventions: Ventana Fenestrated Stent Graft System; Device
Lead sponsor: Endologix; Industry
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 22
States / cities: Birmingham, Alabama • Phoenix, Arizona • Concord, California + 18 more

Search by objective public record fields.

CardioSeq: Impact of WGS in Individuals With CVD

Efficacy of Methods to Treat Multiple Gingival Recession Defects

Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension

Plicated Laparoscopic Adjustable Gastric Banding (Lap Band)

A Study to Test the SENSE Device in Military-Age Patients With Traumatic Brain Injury

An International, Multicenter, Prospective Registry on Post-traumatic Long Bones Defects

A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation

Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids

A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)

Postpartum Glucose Tolerance With Levonorgesterel IUD Use in Women With Recent Gestational Diabetes

Web-based Management of Pediatric Functional Abdominal Pain

CellFX Treat & Resect Low-Risk BCC Feasibility Study

Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.

Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients

Preemptive Local Anesthesia in Vaginal Surgery

A Prospective Double-Blind Study of Retrovir in Early HIV Infection

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

Trial of Efficacy of the RetroPerc Device

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids

Clears On the Day of Anesthesia Permissible up to One-Hour Prior (CODA-POP) to Surgery

A Comparison of Two Socket Sealing Collagen Matrices for Extraction Socket Management

Postoperative Hip Precautions After Total Hip Arthroplasty Via the Posterior Approach: A Prospective Randomized Trial

Safety and Effectiveness Trial of the Ventana Fenestrated Stent Graft System